Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY – Get Free Report) shares saw strong trading volume on Thursday following a better than expected earnings announcement. 728,887 shares changed hands during trading, an increase of 79% from the previous session’s volume of 406,267 shares.The stock last traded at $19.10 and had previously closed at $19.04.
The company reported $0.30 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.05. The firm had revenue of $3.65 billion during the quarter, compared to the consensus estimate of $3.88 billion. Daiichi Sankyo had a net margin of 15.40% and a return on equity of 18.39%.
Wall Street Analyst Weigh In
Separately, Zacks Research lowered Daiichi Sankyo from a “hold” rating to a “strong sell” rating in a research report on Wednesday, November 19th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, Daiichi Sankyo currently has an average rating of “Moderate Buy”.
Daiichi Sankyo Trading Down 6.1%
The firm has a 50-day moving average price of $21.81 and a 200-day moving average price of $23.51. The company has a current ratio of 2.31, a quick ratio of 1.60 and a debt-to-equity ratio of 0.06. The stock has a market capitalization of $34.48 billion and a PE ratio of 17.17.
About Daiichi Sankyo
Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.
Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.
Featured Articles
- Five stocks we like better than Daiichi Sankyo
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.
